Immunogenicity and safety of standard-titer AIK-C measles vaccine in nine-month-old infants

Viral Immunology

Volumn 12, Issue 4, 1999, Pages 343-348

  Tsai, Hsiu Yuan ^a   Huang, Li Min ^b   Shih, Yung Tai ^c   Chen, Jong Ming ^b   Jiang, Tzong Ming ^c   Tsai, Chang Hai ^c   Lee, Chin Yun ^b  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HUMAN; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VIRUS; RANDOMIZED CONTROLLED TRIAL; RASH; RHINORRHEA; SEROCONVERSION; STRAIN DIFFERENCE; VACCINE PRODUCTION;

EID: 0033403150     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1999.12.343     Document Type: Article

References (34)

1. Aaby, P., J. Bukh, D. Kronborg, I.M. Lisse, and M.C. da Silva. 1990. Delayed excess mortality after exposure to measles during the first six month of life. Am. J. Epidemiol. 132:211-219.
2. Aaby, P., J. Bukh, I.M. Lisse, and M.C. da Silva. 1988. Further community studies on the role of overcrowding and intensive exposure on measles mortality. Rev. Infect. Dis. 10:474-477.
3. Aaby, P., K. Knudsen, H. Whittle, I.M. Lisse, J. Thaarup, A. Poulsen, M. Sodemann, M. Jakobsen, L. Brink, and U. Gansted. 1993. Long term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rate. J. Pediatr. 122:904-908.
4. Albrecht, P., F.A. Ennis, E.J. Saltzman, and S. Krugman. 1977. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J. Pediatr. 91:715-718.
5. Anonymous. 1998. Advances in global measles control and elimination: summary of the 1997 international meeting. M.M.W.R. 47:1-23.
6. Bolotovski, V.M., M. Grabowsky, C.J. Clements, P. Albrecht, E.R. Brenner, A.I. Zargaryantzs, S.K. Litvinov, and I.V. Mikheyeva. 1994. Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine. Int. J. Epidemiol. 23:1069-1077.
7. Boteler, L.W., P.M. Luipersbeck, D.A. Fuccillo, and A.J. O'Beirne. 1983. Enzyme-linked immunosorbent assay for detection of measles antibody. J. Clin. Microbiol. 17:814-818.
8. Chiu, H.H., C.Y. Lee, T.W. Chih, P.I. Lee, L.Y. Chang, Y.J. Lin, C.M. Hsu, and L.M. Huang. 1997. A seroepidemiological study of measles after nationwide MMR revaccination programs in Taiwan. J. Med. Virol. 51:32-35.
9. Cutts, F.T., B. Nyandu, L.E. Markowitz, T. Forsey, E.R. Zell, O. Othepa, and K. Wilkins. 1994. Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium- or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, Zaire. Vaccine. 12:1311-1316.
10. Diaz-Ortega, J.L., M. Luna-Abascal, J.L. Valdespino, J. Sepulveda, L.E. Markowitz, and E.R. Zell. 1992. Mortality and morbidity after high-titre measles vaccine in Mexico [letter]. Lancet 340:924.
11. Expanded Programme on Immunization. 1992. Global Advisory Group. Wkly. Epidemiol. Rec. 67:357-361.
12. Garenne, M., O. Leroy, J.O. Beau, and I. Sene. 1991. Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet. 338:903-907.
13. Gendrel, D., D. Garin, C. Dutailly, E. Engohan, C. Gendrel, A. Moussavou, and B. Hamono. 1988. Immunisation of young infants with high doses of Schwarz measles vaccine. Pediatr. Infect. Dis. 7:523-524.
14. Grabowsky, M., S. Rosenthal, and N. Halsey. 1992. Issues for achieving the 1995 measles control targets in developing countries. REACH Monograph, John Snow, Inc., New York.
15. Henderson, R.H., J. Keja, G. Hayden, A. Galazka, J. Clements, and C. Chan. 1988. Immunizing the children of the world: progress and prospects. Bull. World. Health. Organ. 66:535-543.
16. Hirayama, M. 1983. Measles vaccines used in Japan. Rev. Infect. Dis. 5:495-503.
17. Holt, E.A., L.H. Moulton, G.K. Siberry, and N.A. Halsey. 1993. Differential mortality by measles vaccine titer and sex. J. Infect. Dis. 168:1087-1096.
18. Huang, L.M., C.Y. Lee, C.Y. Hsu, S.S. Huang, C.L. Kao, F.F. Wu, C.C. Lee, H.S. Chang, and L.Y. Huang. 1990. Effect of monovalent measles and trivalent measles-mumps-rubella vaccines at various ages and concurrent administration with hepatitis B vaccine. Pediatr. Infect. Dis. J 9:461-465.
19. Job, J.S., N.A. Halsey, R. Boulos, E. Holt, D. Farrell, P. Albrecht, J.R. Brutus, M. Adrien, J. Andre, and E. Chan. 1991. Successful immunization of infants at 6 month of age with high-dose Edmonston-Zagreb measles vaccine. Pediatr. Infect. Dis. J. 10:303-311.
20. Khanum, S., N. Uddin, H. Garelick, G. Mann, and A. Tomkins. 1987. Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection. Lancet. ii:150-153.
21. Lee, J.S., K.H. Hsieh, and C.Y. Lee. 1987. An epidemic of measles during 1984-1985 in Taipei - clinical observations. Acta. Paediatrica. Sinica. 28:234-238.
22. Leon, M.E., B. Ward, R. Kanashiro, H. Hernandez, S. Berry, A. Vaisberg, J. Escamilla, M. Campos, S. Bellomo, V. Azabache, N.A. Halsey. (1993). Immunologic parameters 2 years after high-titer measles immunization in Peruvian children. J. Infect. Dis. 168:1097-1104.
23. Makino, S. 1983. Development and characteristics of live AIK-C measles vaccine: a brief report. Rev. Infect. Dis. 5:504-505.
24. Makino, S., K. Sasaki, N. Nakamura, M. Nakagawa, and S. Nakajima. 1973. Evaluation of the live AIK measles virus vaccine. Kitasato. Arch. Exp. Med. 46:83-92.
25. Makino, S., K. Sasaki, N. Nakamura, M. Nakagawa, and S. Nakajima. 1974. Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK measles virus vaccine. Kitasato. Arch. Exp. Med. 47:13-21.
26. Makino, S., K. Sasaki, T. Nakayama, S. Oka, T. Urano, M. Kimura, R. Kawana, A.M. Yamamura. 1990. A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Findings in clinical and laboratory studies. Am. J. Dis. Child. 144:905-910.
27. Markowitz, L.E., J. Sepulveda, J.L. Diaz-Ortega, J.L. Valdespino, P. Albrecht, E.R. Zell, J. Stewart, M.L. Zarate, and R.H. Bernier. 1990. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. N. Engl. J. Med. 322:580-587.
28. Nakayama, T., T. Urano, M. Osano, M. Nakagawa, N. Maehara, K. Sasaki, and A.M. Yamamura, S. Makino. Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response. Microbiol. Immunol. 34:497-508.
29. Neumann, P.W., J.M. Weber, A.G. Jessamine, and M.V. O'Shaughnessy. 1984. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status. J. Clin. Microbiol. 22:296-298.
30. Tidjani, O., B. Grunitsky, N. Guerin, D. Levy-Bruhl, N. Lecam, C. Xuereff, and K. Tatagan. 1989. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at 4-5 or 8-10 months. Lancet. 2:1357-1360.
31. United Nations Children's Fund. 1992. State of the world's children, 1992. Oxford University Press, New York.
32. Weigle, A.W., M.D. Murphy, and P.A. Brunell. 1984. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. J. Clin. Microbiol. 19:376-379.
33. Whittle, H.C., G. Mann, M. Eccles, K. O'Neill, L. Jupp, P. Hanlon, L. Hanlon, and V. Marsh. 1988. Effects of titer and strain of vaccine on success of measles vaccination of infants aged 4-5 months. Lancet 1:963-966.
34. Whittle, H.C., M.G.M. Rowland, G.F. Mann, W.H. Lamb, and R.A. Lewis. 1984. Immunization of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine. Lancet. 2:834-837.